Skip to content

Supplier News

Perrigo releases generic Mucinex

Perrigo Co. has begun shipping guaifenesin extended-release tablets 600 mg, a generic version of Mucinex tablets. Perrigo said the launch entails product packaged in bottles "to a number of customers.

AstraZeneca launches Dutoprol

AstraZeneca has introduced Dutoprol Tablets, an anti-hypertension medication that the company described as the first and only once-daily combination with the active ingredient of Toprol-XL (metoprolol succinate) extended-release tablets plus low-dose hydrochlorothiazide, offering the dual efficacy o

Prasco to roll out vancomycin capsules

Prasco Laboratories is releasing an authorized generic version of Vancocin Hydrochloride Capsules. Prasco said Wednesday that it will exclusively sell and distribute the authorized generic, which comes in strengths of 125 mg and 250 mg, as part of a distribution and supply pact with ViroPharma Inc.

Takeda to acquire URL Pharma

Takeda Pharmaceutical Co. plans to buy URL Pharma Inc. for $800 million. The companies said Wednesday that the deal, which also includes future performance-based payments to Takeda, is expected to close within the next couple of months.

Watson, Akorn release generic Vancocin

Watson Pharmaceuticals Inc. and Akorn Inc. have shipped vancomycin hydrochloride capsules, an antibiotic used to treat infections of the intestines that cause colitis. The companies said Tuesday that their products, offered in strengths of 125 mg and 250 mg, are generic versions of ViroPharma Inc.

Cardinal’s Pharmacy Health Network has impact

Cardinal Health Inc. said its digital advertising network for retail pharmacies has been shown by Nielsen Co. audience research to be an effective way for advertisers to market products to consumers at the point of purchase.

Mylan ships generic version of Tricor

Mylan Inc. has released fenofibrate tablets, a treatment for high cholesterol and triglycerides, in strengths of 48 mg and 145 mg. The company said Friday that its Mylan Pharmaceuticals Inc.

Bausch+Lomb to acquire Ista Pharmaceuticals

Bausch+Lomb has unveiled a $500 million deal to acquire Ista Pharmaceuticals Inc., a maker of branded prescription drugs for eye care. Bausch+Lomb said Monday that the transaction, which has been unanimously approved by the boards of both companies, is slated to close in the second quarter.

Mylan, Watson cleared to market Boniva generic

Mylan Inc. and Watson Pharmaceuticals Inc. have received approval from the Food and Drug Administration to launch a generic version of Roche’s Boniva osteoporosis medication. Mylan said Tuesday that its Mylan Pharmaceuticals Inc. has begun shipping ibandronate sodium tablets 150 mg.